NO20055695L - Tiadiazinforbindelser og anvendelse derav som positive AMPA-reseptormodulatorer - Google Patents
Tiadiazinforbindelser og anvendelse derav som positive AMPA-reseptormodulatorerInfo
- Publication number
- NO20055695L NO20055695L NO20055695A NO20055695A NO20055695L NO 20055695 L NO20055695 L NO 20055695L NO 20055695 A NO20055695 A NO 20055695A NO 20055695 A NO20055695 A NO 20055695A NO 20055695 L NO20055695 L NO 20055695L
- Authority
- NO
- Norway
- Prior art keywords
- branched
- linear
- compounds
- alkyl group
- hydrogen atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0305448A FR2854634B1 (fr) | 2003-05-05 | 2003-05-05 | Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| PCT/FR2004/001070 WO2004099217A1 (fr) | 2003-05-05 | 2004-05-04 | Derives de thiadiazine et leur utilisation comme modulateurs positifs des recepteurs ampa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20055695L true NO20055695L (no) | 2005-12-01 |
Family
ID=33306157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20055695A NO20055695L (no) | 2003-05-05 | 2005-12-01 | Tiadiazinforbindelser og anvendelse derav som positive AMPA-reseptormodulatorer |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7476668B2 (pt) |
| EP (1) | EP1620441A1 (pt) |
| JP (1) | JP4461139B2 (pt) |
| KR (1) | KR100741235B1 (pt) |
| CN (1) | CN100363368C (pt) |
| AR (1) | AR044245A1 (pt) |
| AU (1) | AU2004236005B2 (pt) |
| BR (1) | BRPI0410002A (pt) |
| CA (1) | CA2524377C (pt) |
| EA (1) | EA009240B1 (pt) |
| FR (1) | FR2854634B1 (pt) |
| GE (1) | GEP20084318B (pt) |
| HK (1) | HK1088327A1 (pt) |
| MA (1) | MA27732A1 (pt) |
| MX (1) | MXPA05011823A (pt) |
| MY (1) | MY136694A (pt) |
| NO (1) | NO20055695L (pt) |
| NZ (1) | NZ543214A (pt) |
| UA (1) | UA80046C2 (pt) |
| WO (1) | WO2004099217A1 (pt) |
| ZA (1) | ZA200508660B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005280058B2 (en) | 2004-08-25 | 2010-09-02 | Essentialis, Inc. | Pharmaceutical formulations of potassium ATP channel openers and uses thereof |
| US7799777B2 (en) | 2006-01-05 | 2010-09-21 | Essentialis, Inc. | Salts of potassium ATP channel openers and uses thereof |
| US20110218190A1 (en) * | 2008-11-10 | 2011-09-08 | The Regents Of The University Of California | Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction |
| HUE049460T2 (hu) | 2010-08-10 | 2020-09-28 | Takeda Pharmaceuticals Co | Heterociklusos vegyület és annak alkalmazása ampa receptor pozitív allosztérikus modulátorként |
| JP5901365B2 (ja) * | 2012-03-12 | 2016-04-06 | 株式会社トクヤマ | イミダート化合物の製造方法 |
| EP3311842A1 (en) | 2013-06-13 | 2018-04-25 | VeroScience LLC | Compositions and methods for treating metabolic disorders |
| CA2991400C (en) | 2015-07-06 | 2020-05-12 | Public University Corporation Yokohama City University | Phenylsulphonamide derivatives useful as ampa receptor imaging agents |
| JP6241974B1 (ja) | 2017-01-11 | 2017-12-06 | 公立大学法人横浜市立大学 | 霊長類生体の脳内ａｍｐａ受容体のイメージング方法、プログラム、及びスクリーニング方法 |
| US10680583B1 (en) * | 2019-02-26 | 2020-06-09 | Xilinx, Inc. | Control circuit for and method of controlling an operation of an integrated circuit device |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3733409A (en) * | 1969-05-20 | 1973-05-15 | Schering Corp | Method of treating hypertension using thieno (1,2,4) thiadiazines |
| AU4345297A (en) * | 1996-09-17 | 1998-04-14 | Regents Of The University Of California, The | Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor |
| KR20010021936A (ko) * | 1997-07-16 | 2001-03-15 | 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 | 융합된 1,2,4-티아디아진 유도체, 그의 제조와 사용 |
| CA2320354A1 (en) * | 1998-02-18 | 1999-08-26 | Neurosearch A/S | Novel compounds and their use as positive ampa receptor modulators |
| FR2801587B1 (fr) * | 1999-11-30 | 2002-01-11 | Adir | Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2003
- 2003-05-05 FR FR0305448A patent/FR2854634B1/fr not_active Expired - Fee Related
-
2004
- 2004-04-05 UA UAA200511454A patent/UA80046C2/uk unknown
- 2004-04-30 MY MYPI20041647A patent/MY136694A/en unknown
- 2004-05-04 CN CNB200480014886XA patent/CN100363368C/zh not_active Expired - Fee Related
- 2004-05-04 JP JP2006505830A patent/JP4461139B2/ja not_active Expired - Fee Related
- 2004-05-04 EP EP04742632A patent/EP1620441A1/fr not_active Withdrawn
- 2004-05-04 AU AU2004236005A patent/AU2004236005B2/en not_active Ceased
- 2004-05-04 GE GEAP20049092A patent/GEP20084318B/en unknown
- 2004-05-04 CA CA2524377A patent/CA2524377C/fr not_active Expired - Fee Related
- 2004-05-04 US US10/555,743 patent/US7476668B2/en not_active Expired - Fee Related
- 2004-05-04 ZA ZA200508660A patent/ZA200508660B/en unknown
- 2004-05-04 KR KR1020057020817A patent/KR100741235B1/ko not_active IP Right Cessation
- 2004-05-04 AR ARP040101515A patent/AR044245A1/es unknown
- 2004-05-04 WO PCT/FR2004/001070 patent/WO2004099217A1/fr active Application Filing
- 2004-05-04 MX MXPA05011823A patent/MXPA05011823A/es active IP Right Grant
- 2004-05-04 BR BRPI0410002-6A patent/BRPI0410002A/pt not_active IP Right Cessation
- 2004-05-04 EA EA200501696A patent/EA009240B1/ru not_active IP Right Cessation
- 2004-05-04 NZ NZ543214A patent/NZ543214A/en not_active IP Right Cessation
-
2005
- 2005-10-21 MA MA28567A patent/MA27732A1/fr unknown
- 2005-12-01 NO NO20055695A patent/NO20055695L/no not_active Application Discontinuation
-
2006
- 2006-08-10 HK HK06108870A patent/HK1088327A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN100363368C (zh) | 2008-01-23 |
| MXPA05011823A (es) | 2006-05-25 |
| JP4461139B2 (ja) | 2010-05-12 |
| FR2854634A1 (fr) | 2004-11-12 |
| WO2004099217A1 (fr) | 2004-11-18 |
| CA2524377C (fr) | 2010-08-24 |
| BRPI0410002A (pt) | 2006-04-25 |
| CA2524377A1 (fr) | 2004-11-18 |
| NZ543214A (en) | 2009-02-28 |
| CN1798750A (zh) | 2006-07-05 |
| AU2004236005B2 (en) | 2010-01-21 |
| UA80046C2 (en) | 2007-08-10 |
| US7476668B2 (en) | 2009-01-13 |
| MY136694A (en) | 2008-11-28 |
| AU2004236005A1 (en) | 2004-11-18 |
| JP2006525292A (ja) | 2006-11-09 |
| GEP20084318B (en) | 2008-03-10 |
| KR20060006830A (ko) | 2006-01-19 |
| US20070004709A1 (en) | 2007-01-04 |
| ZA200508660B (en) | 2007-01-31 |
| EA200501696A1 (ru) | 2006-06-30 |
| EP1620441A1 (fr) | 2006-02-01 |
| EA009240B1 (ru) | 2007-12-28 |
| MA27732A1 (fr) | 2006-01-02 |
| KR100741235B1 (ko) | 2007-07-19 |
| HK1088327A1 (en) | 2006-11-03 |
| AR044245A1 (es) | 2005-09-07 |
| FR2854634B1 (fr) | 2005-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20055695L (no) | Tiadiazinforbindelser og anvendelse derav som positive AMPA-reseptormodulatorer | |
| PL373888A1 (en) | 3-heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides | |
| CA2565660A1 (en) | Ortho substituted aryl or heteroaryl amide compounds | |
| WO2005105732A8 (en) | Substituted methyl aryl or heteroaryl amide compounds | |
| MY142807A (en) | Benzimidazole derivative and use thereof. | |
| WO2008108386A1 (ja) | 医薬組成物 | |
| CA2536870A1 (en) | Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists | |
| TW200510381A (en) | Novel 2-pyridinecarboxamide derivatives | |
| NO20076006L (no) | Acetylenderivater | |
| NO20072409L (no) | Substituerte n-sulfonylaminobenzyl-2-fenoksy acetamid-forbindelser | |
| EP1642880A4 (en) | PROTEIN INHIBITOR OF THE HSP90 FAMILY | |
| DE60129210D1 (de) | Zyklische amid-derivate | |
| MY145746A (en) | Heterocyclic substituted pyridine derivatives and antifungal agent containing same | |
| NO20071008L (no) | Fremgangsmate for fremstilling av N-piperidino-1,5-difenylpyrazol-3-karboksamidderivater | |
| EA201071012A1 (ru) | Производные азетидинов, способ их получения и применение их в терапии | |
| ATE271045T1 (de) | Sauerstoffhaltige heterocyclische verbindungen | |
| HUP0303801A2 (hu) | Heterociklusos alkoxi-, alkil-tio- és alkil-amino-benzazol-származékok, mint 5-hidroxi-triptamin-6 ligandumok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| WO2007068815A3 (fr) | Derives heterocycliques, leur preparation et leur application en therapeutique. | |
| ATE377598T1 (de) | Durch bicyclische aminogruppen substituierte verbindungen | |
| MX2010010471A (es) | Derivado de tetrahidroisoquinolina novedoso. | |
| DE60002558D1 (de) | Derivate der Phosphonsäure zur Inhibierung von Carboxypeptidase B | |
| NO20070972L (no) | Benzyloksyderivater som MAOB-inhibitorer | |
| NO20053997D0 (no) | Oligosaccharidderivat | |
| NO20065323L (no) | 6-substituerte pyridoindolonderivater, fremstilling og anvendelse derav | |
| MY134226A (en) | 1,2-dihydropyrazol-3-ones which control inflammatory cyctokines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |